Design Therapeutics DSGN
NASDAQ DSGN
$10.55 -0.25 (-2.31%)
As of: Nov 10, 2026 · 3:05 PM EST

Design Therapeutics (DSGN) Net Margin (2020)

Updated

Design Therapeutics (DSGN) recorded Net Margin of -11681.82% in Q4 2020, down 81.82 percentage points from the prior quarter.

Analysis

Design Therapeutics (DSGN) Net Margin (2020) Analysis & Trends

For FY2020, Design Therapeutics reported Net Margin of -3663.72%.

  • Per Business Quant, the preceding three quarters came in at -11600.00% (Q3 2020), -4651.61% (Q2 2020) and -466.90% (Q1 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 26.44%
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 0.83%
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 24.24%
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 28.01%
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 22.65%
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 16.30%
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 37.28%
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 29.27%
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 19.55%
10 Design Therapeutics 678.89 Mn -179.78 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -11,681.82%
Sep 30, 2020 -11,600.00%
Jun 30, 2020 -4,651.61%
Mar 31, 2020 -466.90%
API Access

Design Therapeutics Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=DSGN&period=max&api_key=YOUR_API_KEY